Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05906394Not ApplicableCompleted

A Pre-market Study to Evaluate b.Bone for Posterolateral Fusion (b.Spine Clinical Trial).

Role: lead

NCT03884790Not ApplicableTerminated

Pre-market Study to Evaluate Safety and Performance of GreenBone Implant (Long Bone Study)

Role: lead

NCT06156904Recruiting

OSsIRIS Study - A Post-market Clinical Follow-up Investigation.

Role: lead

NCT03836404Not ApplicableCompleted

Pre-market Study to Evaluate Safety and Performance of GreenBone Implant

Role: lead

All 4 trials loaded